- Home
- PSF vs SMTI Comparison
PSF vs SMTI Comparison
Compare PSF & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- SMTI
- Stock Information
- Founded
- PSF 2010
- SMTI 1982
- Country
- PSF United States
- SMTI United States
- Employees
- PSF N/A
- SMTI N/A
- Industry
- PSF Investment Managers
- SMTI Medical/Dental Instruments
- Sector
- PSF Finance
- SMTI Health Care
- Exchange
- PSF Nasdaq
- SMTI Nasdaq
- Market Cap
- PSF 256.1M
- SMTI 256.9M
- IPO Year
- PSF N/A
- SMTI N/A
- Fundamental
- Price
- PSF $21.25
- SMTI $31.54
- Analyst Decision
- PSF
- SMTI Buy
- Analyst Count
- PSF 0
- SMTI 1
- Target Price
- PSF N/A
- SMTI $44.00
- AVG Volume (30 Days)
- PSF 25.0K
- SMTI 29.5K
- Earning Date
- PSF 01-01-0001
- SMTI 11-11-2024
- Dividend Yield
- PSF 7.69%
- SMTI N/A
- EPS Growth
- PSF N/A
- SMTI N/A
- EPS
- PSF N/A
- SMTI N/A
- Revenue
- PSF N/A
- SMTI $72,410,222.00
- Revenue This Year
- PSF N/A
- SMTI $26.97
- Revenue Next Year
- PSF N/A
- SMTI $18.91
- P/E Ratio
- PSF N/A
- SMTI N/A
- Revenue Growth
- PSF N/A
- SMTI 21.42
- 52 Week Low
- PSF $16.00
- SMTI $26.00
- 52 Week High
- PSF $20.19
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- PSF 62.22
- SMTI 49.87
- Support Level
- PSF $21.22
- SMTI $28.30
- Resistance Level
- PSF $21.39
- SMTI $32.51
- Average True Range (ATR)
- PSF 0.16
- SMTI 1.75
- MACD
- PSF -0.04
- SMTI 0.17
- Stochastic Oscillator
- PSF 28.57
- SMTI 67.46
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.